Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Dyax phage display technology receives patent protection

May 10, 1996

CEPRATE SC approvable for autologous BMT

May 10, 1996

Optex receives NIH grant to develop Catarex

May 10, 1996

Sterizone System to be evaluated in Cornell study

May 10, 1996

CR1 technology licensed to CytoTherapeutics

May 10, 1996

Gryphon, SKB to study mirror image proteins

May 10, 1996

Hyal to study agents for macular degeneration

May 10, 1996

RiboGene and Abbott collaborate on antifungal drugs

May 10, 1996

BioChem, Oncogene to investigate treatments for HCV, HIV

May 10, 1996

Gensia coagulation monitoring system enters phase I

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...